United Therapeutics announced its participation in the RBC Capital Markets Global Healthcare Conference scheduled for May 19, 2026. The RBC Capital Markets Global Healthcare Conference session will feature James Edgemond, Chief Financial Officer and Treasurer of the company. He will provide a company overview and business update during the event.
The presentation will take place in New York from 9:30 a.m. to 9:55 a.m. EST. United Therapeutics confirmed that investors and attendees can access the session through a live webcast hosted on the company’s investor relations website. The company also stated that a recorded version will remain available for 90 days after the conference session concludes.
Investor Webcast and Conference Details
The RBC Capital Markets Global Healthcare Conference continues to attract healthcare and biotechnology companies discussing business performance and strategic updates. United Therapeutics said James Edgemond will present a company overview during the conference event in New York.
The presentation can be accessed via a live webcast on the United Therapeutics website. An archived, recorded version of the session will be available approximately 24 hours after the session ends.
United Therapeutics develops therapies focused on rare diseases and alternatives for transplantable organs. The company’s investor relations portal includes webcast access and additional event information related to the RBC Capital Markets Global Healthcare Conference.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
